Alpha Genesis Expands U.S. Primate Breeding Operations by 40% to Advance U.S. Scientific Self-Reliance

November 11, 2025 9:00 AM

Alpha Genesis, Inc. (AGI), a leading U.S. provider of nonhuman primates and biomedical research services, has expanded its South Carolina breeding operations by 40 percent to reduce the costs, delays, and uncertainties associated with imported research animals. The expansion adds 1,200 new research-ready spaces and allows AGI to offer the most competitive animal pricing, per-diem rates, and lead times in the industry, strengthening America's...

Read more

CLS Health Celebrates 20 Years of Delivering Physician-Led, Patient-Centered Care

November 11, 2025 9:00 AM

Two decades ago, CLS Health was created as a physician-owned, physician-led healthcare system to serve the Greater Houston area, placing clinical decision-making in the hands of physicians. Now, having grown to more than 225 doctors and healthcare professionals across 45 medical specialties, CLS Health is marking its anniversary on October 26 with community events, charitable initiatives, and stories about physician leadership in improving care...

Read more

Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025

November 11, 2025 8:45 AM

Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathy, today announced it has successfully enrolled the first 100 patients in its ongoing HALT-CINP Phase 2b CINP trial. HALT-CINP remains on track to conduct a prespecified interim analysis during the fourth quarter of 2025 on patients who have completed or been terminated from the four-week...

Read more

NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

November 11, 2025 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it has entered into a securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are expected to be approximately $6...

Read more

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

November 11, 2025 8:21 AM

VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step forward, VSee is integrating advanced robotic assistance into intensive care units (ICUs), enabling remote clinicians to monitor and intervene in real-time - potentially transforming critical care delivery....

Read more

Who is the Best MTF Top Surgeon?

November 11, 2025 8:00 AM

In the conversations around male-to-female (MTF) transgender top surgery (breast augmentation), one name has risen to the top: Dr. Javad Sajan of Allure Esthetic in Seattle. Dr. Sajan is widely regarded as the best MTF top surgeon, known for pioneering a scarless approach to breast augmentation that is transforming outcomes for transgender women. By performing MTF breast augmentation through hidden incisions, he virtually eliminates chest scars,...

Read more

Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing

November 11, 2025 8:00 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the pricing of an at-the-market private investment in public equity (the "PIPE") financing with several accredited investors for total gross proceeds of $2,850,000.The PIPE is designed to provide accretive capital through participation from strategic industry partners and members of...

Read more

Clip on Veneers - Instasmile 2025's Affordable Smile Make Over

November 11, 2025 7:16 AM

As Americans face record-high dental care costs - with 46% skipping or delaying treatment due to price pressures (ADA Health Policy Institute, USA Today, 2025) - affordable cosmetic dentistry is more relevant than ever. Yet the global cosmetic dentistry market continues to expand, projected to grow 13.5% annually through 2030, reaching $89 billion worldwide (Grand View Research, 2023). Amid this paradox of inflation and demand, instasmile, the...

Read more

Senzime to Present at Redeye and BioStock Investor Conferences

November 11, 2025 7:15 AM

Senzime (STO:SEZI)(OTCQX:SNZZF), a leader in solutions for personalized anesthesia, today announced that Philip Siberg, CEO of Senzime, will be presenting at the following investor conferences this week.Redeye Medtech & Diagnostics Theme EventDate: Nov 12, 2025Time: 11:45 CETEvent Page: https://www.redeye.se/events/1110236/redeye-theme-medtech-diagnostics-4Biostock SummitDate: Nov 13, 2025Time: 14:40 CETEvent Page:...

Read more

Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review

November 11, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced a special session of its "Fourth Friday at Four" investor webinar series. To accommodate the holiday calendar, this month's webinar will be held on the third Friday-November 21, 2025 at 4:00 p.m. Eastern Time.The November program will provide a comprehensive...

Read more

SoftWriters Launches Alpha Labs Team to Advance AI and Automation Innovation

November 11, 2025 6:00 AM

SoftWriters, the leading provider of pharmacy management solutions for long-term care pharmacies, today announced the creation of Alpha Labs, a new cross-functional innovation team dedicated to accelerating the company's artificial intelligence (AI) and automation strategy.The Alpha Labs team will focus on identifying the optimal pathways to unlock AI and automation across SoftWriters' product suite. With a clear roadmap and validated product...

Read more

Mentavi Health Introduces "Mentavi Concierge" - Setting a New Standard for Responsible AI in Digital Health

November 11, 2025 6:00 AM

Mentavi Health, a leader in evidence-based digital mental health care, has launched Mentavi Concierge, its next-generation AI support assistant that enhances the digital health journey of visitors and patients while keeping human clinicians at the center of care.Mentavi Concierge represents the company's belief in the ethical use of AI: as a powerful tool for access, efficiency, and personalization - but never as a replacement for human clinical...

Read more

AlzeCure Publishes its Interim Report for January - September 2025

November 11, 2025 2:15 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - September 2025 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/"The third quarter of 2025 was an active and eventful quarter for AlzeCure Pharma. In July, we received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA)...

Read more

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

November 10, 2025 6:15 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2025, after the stock market closes on Thursday, November 13, 2025. The Company will hold a conference call with the investment...

Read more

FACT's New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

November 10, 2025 6:10 PM

The Foundation for the Accreditation of Cellular Therapy (FACT) today published the Standards for Immune Effector Cells in the Community Clinical Setting, 1st edition, to help community oncology programs deliver transformative cell therapies closer to where eligible patients live and work."These Standards, and FACT's accompanying voluntary accreditation, will help assure community-based caregivers, patients, and all stakeholders that the patient...

Read more

CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ

November 10, 2025 4:05 PM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that it has received a letter dated November 5, 2025, with a delisting determination from Nasdaq Stock Market LLC (the "Determination").As previously reported, on May 5, 2025, Nasdaq...

Read more

The National Children's Cancer Society (NCCS) Announces New Mission and Vision Statements Reflecting Its Continued Commitment to Families Impacted by Childhood Cancer

November 10, 2025 4:00 PM

The National Children's Cancer Society (NCCS), a leading nonprofit dedicated to supporting children with cancer, their families, and survivors, has announced a new mission statement that reflects the organization's expanded and comprehensive approach to care.For 38 years, the NCCS has stood beside families navigating the challenges of childhood cancer, offering support where it's needed most. Founded in 1987 by Mark and Carol Stolze and Mark's...

Read more

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025

November 10, 2025 3:50 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2025.Revenue for the quarters ended September 30, 2025 was $12.7 million compared to $13.6 million for the quarter ended September 30, 2024, a decrease of $0.9 million or approximately 6.6%. The Company had operating income for the quarter ended September 30, 2025 and 2024 of approximately $0.2 million and $0.5...

Read more

Reporting Of Transactions Made By Persons Discharging Managerial Responsibilities And Persons Closely Associated With Them In Gubra A/S' Shares

November 10, 2025 3:45 PM

Gubra (CPH:GUBRA)Pursuant to the Market Abuse Regulation article 19, Gubra A/S, CVR no. 30514041 (the "Company") hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in the Company and persons closely associated with them in the Company's shares and other financial instruments linked thereto.1.Details of the person discharging managerial responsibilities/person closely...

Read more

Federal Marijuana Crackdown Confirms the Future: DEA's Obstruction of MMJ Science Exposed as Congress Moves to Re-Criminalize the $30 Billion THC Gray Market

November 10, 2025 2:15 PM

The chaotic, multi-billion dollar cannabis gray market created by the 2018 Farm Bill will soon be officially over. Simultaneous actions by the federal government-Congressional legislation, a unified front of 39 State Attorneys General, and local law enforcement sweeps-confirm that only fully compliant pharmaceutical grade companies will define the future of cannabis in medicine. This regulatory convergence directly validates the decade long...

Read more